ArticleOncotarget2016

Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy.

Jiang-Jiang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.